Article

Vitamin D deficiency linked with osteoarthritis in older men

There is a high prevalence of 25-hydroxyvitamin D (25[OH]D) deficiency in older men who have radiographic hip osteoarthritis (OA). Because 25(OH)D plays a significant role in bone and cartilage maintenance, therapeutic interventions with vitamin D are warranted to augment their skeletal health.

There is a high prevalence of 25-hydroxyvitamin D (25[OH]D) deficiency in older men who have radiographic hip osteoarthritis (OA). Because 25(OH)D plays a significant role in bone and cartilage maintenance, therapeutic interventions with vitamin D are warranted to augment their skeletal health.

Chaganti and colleagues measured serum levels of vitamin D in 1104 participants in the Osteoporotic Fractures in Men Study; almost 5 years later, they obtained pelvic radiographs and examined them for evidence of hip OA. The investigators used logistic regression to evaluate the relationship between vitamin D levels and hip OA and looked at other variables, including the patient’s age, self-reported hip pain and health status, and timed 6-meter walk.

Vitamin D deficiency was clearly and significantly linked with hip OA. Men who lacked vitamin D had a 2-fold increased likelihood of prevalent radiographic hip OA. They also had more hip pain and a slower walk time. Men who had radiographic hip OA had a higher prevalence of vitamin D insufficiency and frank deficiency compared with the men who did not.

The authors noted that the association of low 25(OH)D levels with prevalent radiographic hip OA underscores the important role of vitamin D in the pathogenesis of OA.

Related Videos
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
Søren Andreas Just, MD, PhD: Developing AI to Mitigate Rheumatologist Shortages for Disease Assessment
© 2024 MJH Life Sciences

All rights reserved.